Trial site
Klinikum Frankfurt Hoechst GmbH
- 13running trials
- 1closed trial
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Stroke4 trials
- Metastatic breast cancer3 trials
- Triple-negative breast cancer3 trials
- Atrial fibrillation2 trials
- Lung cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Gastric and oesophageal cancer1 trial
- Myelodysplastic syndromes1 trial
- Ovarian cancer1 trial
- Phase
- Phase 311 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Recruiting10 trials
- Active, not recruiting3 trials
- Completed1 trial
- Lead sponsor
- AstraZeneca2 trials
- AGO Study Group1 trial
- Bayer AG1 trial
- Boehringer Ingelheim1 trial
- Gilead Sciences1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Active, not recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Recruiting
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)
Active, not recruiting
Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke3 recruiting
- Metastatic breast cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Acute myeloid leukaemia1 recruiting
- Atrial fibrillation1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026